Related Experiment Videos
Interleukin-2 stimulation activates mesothelial cellular functioning against autologous tumor cells
Yuh-Min Chen1, Yi-Lin Hsieh, Chun-Ming Tsai
1Chest Department, Taipei Veterans General Hospital and National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC. ymchen@vghtpe.gov.tw
Journal of the Chinese Medical Association : JCMA
|October 30, 2004
Summary
Interleukin-2 (IL-2) alone enhances mesothelial cell proliferation and tumor cell killing. IL-2 also shifts the T-helper cell response towards Th-1, indicating a potential therapeutic avenue for malignant pleural effusion.
Area of Science:
- Immunology
- Cell Biology
- Oncology
Background:
- Mesothelial cells play a role in malignant pleural effusion.
- Cytokines and antibodies can modulate cellular functions.
Purpose of the Study:
- To investigate the effects of various cytokines and antibodies on mesothelial cells.
- To determine the impact of IL-2 on mesothelial cell proliferation and cytolytic activity.
Main Methods:
- Mesothelial cells were isolated from 27 patients with malignant pleural effusion.
- Assessed interferon-gamma (IFNγ) and IL-10 production, proliferation, and cytolytic activity.
- Stimulated cells with IL-2, IL-4, IL-7, IL-10, IL-12, and αCD3.
Main Results:
- IL-2 significantly increased mesothelial cell proliferation and cytolytic activity against autologous tumors.
- IL-2 stimulation shifted the T-helper (Th) pathway from Th-2 to Th-1, indicated by an increased IFNγ/IL-10 ratio.
- Further stimulation with IL-2 plus IL-12 or αCD3 enhanced the Th-1 shift, though not significantly.
Conclusions:
- IL-2 alone effectively enhances mesothelial cell proliferation and cytolytic activity against tumor cells.
- IL-2 stimulation promotes a shift towards a Th-1 immune response.
- Findings suggest IL-2 as a potential therapeutic agent for augmenting anti-tumor activity in malignant pleural effusion.